Betting on biomarkers

Editorial

Roy H Perlis. Am J Psychiatry. 2011 Mar.

. 2011 Mar;168(3):234-6.

doi: 10.1176/appi.ajp.2010.10121738.

No abstract available

Comment on

Pharmacogenetic approach at the serotonin transporter gene as a method of reducing the severity of alcohol drinking.
Johnson BA, Ait-Daoud N, Seneviratne C, Roache JD, Javors MA, Wang XQ, Liu L, Penberthy JK, DiClemente CC, Li MD. Johnson BA, et al. Am J Psychiatry. 2011 Mar;168(3):265-75. doi: 10.1176/appi.ajp.2010.10050755. Epub 2011 Jan 19. Am J Psychiatry. 2011. PMID: 21247998 Free PMC article. Clinical Trial.

Functional biomarkers of depression: diagnosis, treatment, and pathophysiology.
Schmidt HD, Shelton RC, Duman RS. Schmidt HD, et al. Neuropsychopharmacology. 2011 Nov;36(12):2375-94. doi: 10.1038/npp.2011.151. Epub 2011 Aug 3. Neuropsychopharmacology. 2011. PMID: 21814182 Free PMC article. Review.
Electroretinographic modifications induced by agomelatine: a novel avenue to the understanding of the claimed antidepressant effect of the drug?
Fornaro M, Bandini F, Cestari L, Cordano C, Ogliastro C, Albano C, De Berardis D, Martino M, Escelsior A, Rocchi G, Fornaro P, De Pasquale C. Fornaro M, et al. Neuropsychiatr Dis Treat. 2014 May 20;10:907-14. doi: 10.2147/NDT.S63459. eCollection 2014. Neuropsychiatr Dis Treat. 2014. PMID: 24899809 Free PMC article.

1. Johnson BA, Ait-Daoud N, Seneviratne C, Roache JD, Javors MA, Wang X-Q, Liu L, Penberthy JK, DiClemente CC, Li MD. Pharmacogenetic approach at the serotonin transporter gene as a method of reducing the severity of alcohol drinking. Am J Psychiatry. 2011;168:265–275. - PMC - PubMed
1. Simon RM, Paik S, Hayes DF. Use of archived specimens in evaluation of prognostic and predictive biomarkers. J Natl Cancer Inst. 2009;101:1446–1452. - PMC - PubMed
1. Salloway S, Sperling R, Gilman S, Fox NC, Blennow K, Raskind M, Sabbagh M, Honig LS, Doody R, van Dyck CH, Mulnard R, Barakos J, Gregg KM, Liu E, Lieberburg I, Schenk D, Black R, Grundman M Bapineuzumab 201 Clinical Trial Investigators. A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease. Neurology. 2009;73:2061–2070. - PMC - PubMed
1. Bachner-Melman R, Dina C, Zohar AH, Constantini N, Lerer E, Hoch S, Sella S, Nemanov L, Gritsenko I, Lichtenberg P, Granot R, Ebstein RP. AVPR1a and SLC6A4 gene polymorphisms are associated with creative dance performance. PLoS Genet. 2005;1(3):e42. - PMC - PubMed
1. Ioannidis JP. Why most published research findings are false. PLoS Med. 2005;2(8):e124. - PMC - PubMed